Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 307

1.

Additional fibrate treatment in UDCA-refractory PBC patients.

Chung SW, Lee JH, Kim MA, Leem G, Kim SW, Chang Y, Lee HY, Yoon JS, Park JY, Lee YB, Cho EJ, Yu SJ, Kim YJ, Yoon JH.

Liver Int. 2019 Jun 4. doi: 10.1111/liv.14165. [Epub ahead of print]

PMID:
31162879
2.

Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data.

Yoon JS, Song BG, Lee JH, Lee HY, Kim SW, Chang Y, Lee YB, Cho EJ, Yu SJ, Sinn DH, Kim YJ, Lee JH, Yoon JH.

BMC Cancer. 2019 May 31;19(1):523. doi: 10.1186/s12885-019-5740-z.

3.

Circulating Microbiota-Based Metagenomic Signature for Detection of Hepatocellular Carcinoma.

Cho EJ, Leem S, Kim SA, Yang J, Lee YB, Kim SS, Cheong JY, Cho SW, Kim JW, Kim SM, Yoon JH, Park T.

Sci Rep. 2019 May 17;9(1):7536. doi: 10.1038/s41598-019-44012-w.

4.

Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B.

Cho YY, Chang Y, Nam JY, Cho H, Cho EJ, Lee JH, Yu SJ, Yoon JH, Kim YJ.

Gut Liver. 2019 May 3. doi: 10.5009/gnl18474. [Epub ahead of print]

5.

Radiologic Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Suppressed Chronic Hepatitis B.

Cho H, Chang Y, Lee JH, Cho YY, Nam JY, Lee YB, Lee DH, Cho EJ, Yu SJ, Kim YJ, Lee JM, Yoon JH.

J Clin Gastroenterol. 2019 Apr 26. doi: 10.1097/MCG.0000000000001217. [Epub ahead of print]

PMID:
31033805
6.

Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma.

Yoo JJ, Yu SJ, Na J, Kim K, Cho YY, Lee YB, Cho EJ, Lee JH, Kim YJ, Youn H, Yoon JH.

Int J Mol Sci. 2019 Mar 14;20(6). pii: E1292. doi: 10.3390/ijms20061292.

7.

Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients.

Park ES, Lee AR, Kim DH, Lee JH, Yoo JJ, Ahn SH, Sim H, Park S, Kang HS, Won J, Ha YN, Shin GC, Kwon SY, Park YK, Choi BS, Lee YB, Jeong N, An Y, Ju YS, Yu SJ, Chae HB, Yu KS, Kim YJ, Yoon JH, Zoulim F, Kim KH.

J Hepatol. 2019 Jun;70(6):1093-1102. doi: 10.1016/j.jhep.2019.02.006. Epub 2019 Feb 20.

PMID:
30794889
8.

Carbonic anhydrase-IX inhibition enhances the efficacy of hexokinase II inhibitor for hepatocellular carcinoma in a murine model.

Cho EJ, Yu SJ, Kim K, Cho H, Cho YY, Lee YB, Lee JH, Kim YJ, Youn H, Yoon JH.

J Bioenerg Biomembr. 2019 Apr;51(2):121-129. doi: 10.1007/s10863-019-09788-6. Epub 2019 Feb 12.

PMID:
30746618
9.

NKX6.3 protects against gastric mucosal atrophy by downregulating β-amyloid production.

Yoon JH, Lee YS, Kim O, Ashktorab H, Smoot DT, Nam SW, Park WS.

World J Gastroenterol. 2019 Jan 21;25(3):330-345. doi: 10.3748/wjg.v25.i3.330.

10.

Hepatitis B virus X protein induces size-selective membrane permeabilization through interaction with cardiolipin.

You DG, Cho YY, Lee HR, Lee JH, Yu SJ, Yoon JH, Yoo YD, Kim YJ, Lee GY.

Biochim Biophys Acta Biomembr. 2019 Apr 1;1861(4):729-737. doi: 10.1016/j.bbamem.2019.01.006. Epub 2019 Jan 16.

PMID:
30658058
11.

Is Combination Antiviral Therapy Mandatory for Maintenance Therapy in Fully Suppressed Multidrug-Resistant Hepatitis B Patients?

Chung SW, Chang Y, Lee HY, Cho EJ, Lee JH, Yu SJ, Yoon JH, Kim YJ.

Gastroenterol Res Pract. 2018 Dec 16;2018:6948235. doi: 10.1155/2018/6948235. eCollection 2018.

12.

Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.

Lee DH, Lee JM, Yu MH, Hur BY, Yi NJ, Lee KW, Suh KS, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK.

Eur Radiol. 2019 Jun;29(6):3122-3131. doi: 10.1007/s00330-018-5941-x. Epub 2019 Jan 14.

PMID:
30643939
13.

An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma.

El Dika I, Lim HY, Yong WP, Lin CC, Yoon JH, Modiano M, Freilich B, Choi HJ, Chao TY, Kelley RK, Brown J, Knox J, Ryoo BY, Yau T, Abou-Alfa GK.

Oncologist. 2019 Jun;24(6):747-e218. doi: 10.1634/theoncologist.2018-0838. Epub 2018 Dec 31.

PMID:
30598500
14.

Analysis of significant protein abundance from multiple reaction-monitoring data.

Jun J, Gim J, Kim Y, Kim H, Yu SJ, Yeo I, Park J, Yoo JJ, Cho YY, Lee DH, Cho EJ, Lee JH, Kim YJ, Lee S, Yoon JH, Kim Y, Park T.

BMC Syst Biol. 2018 Dec 31;12(Suppl 9):123. doi: 10.1186/s12918-018-0656-9.

15.

Multiple genetic mutations caused by NKX6.3 depletion contribute to gastric tumorigenesis.

Yoon JH, Kim O, Eun JW, Choi SS, Ashktorab H, Smoot DT, Nam SW, Park WS.

Sci Rep. 2018 Dec 4;8(1):17609. doi: 10.1038/s41598-018-35733-5.

16.

Timing of upper gastrointestinal endoscopy does not influence short-term outcomes in patients with acute variceal bleeding.

Yoo JJ, Chang Y, Cho EJ, Moon JE, Kim SG, Kim YS, Lee YB, Lee JH, Yu SJ, Kim YJ, Yoon JH.

World J Gastroenterol. 2018 Nov 28;24(44):5025-5033. doi: 10.3748/wjg.v24.i44.5025.

17.

Concomitant food intake does not affect the efficacy of entecavir in chronic hepatitis B patients with virological response: a randomized, multicenter, noninferiority trial.

Cho EJ, Yu SJ, Kwon SY, Kim JH, Kim DY, Kim W, Lee JS, Lee JW, Lee YJ, Chae HB, Yoon JH.

Drug Des Devel Ther. 2018 Nov 2;12:3767-3774. doi: 10.2147/DDDT.S181561. eCollection 2018.

18.

The Model to Estimate Survival in Ambulatory Hepatocellular Carcinoma Patients Aids in the Decision for TACE Retreatment.

Cho YY, Yu SJ, Yoo JJ, Lee M, Lee DH, Cho Y, Yoon KW, Cho EJ, Lee JH, Kim YJ, Yoon JH.

J Clin Gastroenterol. 2018 Nov 14. doi: 10.1097/MCG.0000000000001148. [Epub ahead of print]

PMID:
30439763
19.

Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence.

Kang SH, Cho H, Cho EJ, Lee JH, Yu SJ, Kim YJ, Yi NJ, Lee KW, Suh KS, Yoon JH.

J Korean Med Sci. 2018 Oct 12;33(45):e283. doi: 10.3346/jkms.2018.33.e283. eCollection 2018 Nov 5.

20.

Prognostic Value of Biochemical Response Models for Primary Biliary Cholangitis and the Additional Role of the Neutrophil-to-Lymphocyte Ratio.

Yoo JJ, Cho EJ, Lee B, Kim SG, Kim YS, Lee YB, Lee JH, Yu SJ, Kim YJ, Yoon JH.

Gut Liver. 2018 Nov 15;12(6):714-721. doi: 10.5009/gnl18271.

Supplemental Content

Loading ...
Support Center